Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Free Cash Flow (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Free Cash Flow for 12 consecutive years, with -$60.0 million as the latest value for Q1 2026.

  • For Q1 2026, Free Cash Flow rose 5.08% year-over-year to -$60.0 million; the TTM value through Mar 2026 reached -$185.0 million, down 2.03%, while the annual FY2025 figure was -$188.2 million, 23.85% down from the prior year.
  • Free Cash Flow hit -$60.0 million in Q1 2026 for Wave Life Sciences, down from -$33.8 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $85.0 million in Q1 2023 and bottomed at -$63.2 million in Q1 2025.
  • Average Free Cash Flow over 5 years is -$32.3 million, with a median of -$34.7 million recorded in 2023.
  • Year-over-year, Free Cash Flow plummeted 377.36% in 2022 and then soared 312.15% in 2023.
  • Wave Life Sciences' Free Cash Flow stood at -$33.6 million in 2022, then grew by 0.15% to -$33.6 million in 2023, then crashed by 30.18% to -$43.7 million in 2024, then increased by 22.77% to -$33.8 million in 2025, then crashed by 77.62% to -$60.0 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$60.0 million, -$33.8 million, and -$44.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.